Clinical Trial Update: GSK372475 Bioequivalence Study [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of GSK372475 conducted in healthy subjects and participants with depressive disorder; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• GSK372475

Snippet

Sponsor: GlaxoSmithKline | Conditions: Healthy Subjects, Depressive Disorder | Phase 1 | Status: COMPLETED